nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Methotrexate—psoriatic arthritis	0.139	0.188	CbGbCtD
Gemfibrozil—CYP2C19—Prednisone—psoriatic arthritis	0.0982	0.133	CbGbCtD
Gemfibrozil—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0783	0.106	CbGbCtD
Gemfibrozil—CYP2C8—Dexamethasone—psoriatic arthritis	0.073	0.099	CbGbCtD
Gemfibrozil—CYP2C19—Dexamethasone—psoriatic arthritis	0.0613	0.083	CbGbCtD
Gemfibrozil—CYP3A4—Triamcinolone—psoriatic arthritis	0.0594	0.0804	CbGbCtD
Gemfibrozil—CYP2C9—Dexamethasone—psoriatic arthritis	0.0509	0.069	CbGbCtD
Gemfibrozil—CYP3A4—Betamethasone—psoriatic arthritis	0.0509	0.069	CbGbCtD
Gemfibrozil—CYP3A4—Prednisolone—psoriatic arthritis	0.0503	0.0681	CbGbCtD
Gemfibrozil—CYP3A4—Prednisone—psoriatic arthritis	0.0475	0.0643	CbGbCtD
Gemfibrozil—CYP3A4—Dexamethasone—psoriatic arthritis	0.0296	0.0401	CbGbCtD
Gemfibrozil—Pancreatitis—Triamcinolone—psoriatic arthritis	0.00111	0.00423	CcSEcCtD
Gemfibrozil—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.0011	0.00422	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00107	0.0041	CcSEcCtD
Gemfibrozil—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00105	0.00399	CcSEcCtD
Gemfibrozil—Muscular weakness—Betamethasone—psoriatic arthritis	0.00105	0.00399	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000987	0.00377	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000985	0.00376	CcSEcCtD
Gemfibrozil—Photosensitivity—Methotrexate—psoriatic arthritis	0.000983	0.00375	CcSEcCtD
Gemfibrozil—Weight decreased—Dexamethasone—psoriatic arthritis	0.000927	0.00354	CcSEcCtD
Gemfibrozil—Weight decreased—Betamethasone—psoriatic arthritis	0.000927	0.00354	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.000915	0.00349	CcSEcCtD
Gemfibrozil—Muscular weakness—Prednisone—psoriatic arthritis	0.000911	0.00348	CcSEcCtD
Gemfibrozil—Rhinitis—Triamcinolone—psoriatic arthritis	0.000906	0.00346	CcSEcCtD
Gemfibrozil—Rhinitis—Methylprednisolone—psoriatic arthritis	0.000904	0.00345	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000896	0.00342	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000896	0.00342	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000886	0.00339	CcSEcCtD
Gemfibrozil—Pancreatitis—Prednisone—psoriatic arthritis	0.000875	0.00334	CcSEcCtD
Gemfibrozil—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000843	0.00322	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Prednisone—psoriatic arthritis	0.000822	0.00314	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000813	0.00311	CcSEcCtD
Gemfibrozil—Weight decreased—Prednisone—psoriatic arthritis	0.000807	0.00308	CcSEcCtD
Gemfibrozil—Vision blurred—Prednisolone—psoriatic arthritis	0.000807	0.00308	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000797	0.00304	CcSEcCtD
Gemfibrozil—Depression—Prednisone—psoriatic arthritis	0.000793	0.00303	CcSEcCtD
Gemfibrozil—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00079	0.00302	CcSEcCtD
Gemfibrozil—Angioedema—Prednisolone—psoriatic arthritis	0.000782	0.00299	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00078	0.00298	CcSEcCtD
Gemfibrozil—Breast disorder—Methotrexate—psoriatic arthritis	0.00078	0.00298	CcSEcCtD
Gemfibrozil—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000771	0.00294	CcSEcCtD
Gemfibrozil—Vertigo—Prednisolone—psoriatic arthritis	0.000769	0.00294	CcSEcCtD
Gemfibrozil—Syncope—Prednisolone—psoriatic arthritis	0.000767	0.00293	CcSEcCtD
Gemfibrozil—Eye disorder—Betamethasone—psoriatic arthritis	0.000767	0.00293	CcSEcCtD
Gemfibrozil—Eye disorder—Dexamethasone—psoriatic arthritis	0.000767	0.00293	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000752	0.00287	CcSEcCtD
Gemfibrozil—Convulsion—Prednisolone—psoriatic arthritis	0.000741	0.00283	CcSEcCtD
Gemfibrozil—Eosinophilia—Methotrexate—psoriatic arthritis	0.000738	0.00282	CcSEcCtD
Gemfibrozil—Pancreatitis—Methotrexate—psoriatic arthritis	0.000731	0.00279	CcSEcCtD
Gemfibrozil—Alopecia—Dexamethasone—psoriatic arthritis	0.000725	0.00277	CcSEcCtD
Gemfibrozil—Alopecia—Betamethasone—psoriatic arthritis	0.000725	0.00277	CcSEcCtD
Gemfibrozil—Angioedema—Triamcinolone—psoriatic arthritis	0.000719	0.00275	CcSEcCtD
Gemfibrozil—Angioedema—Methylprednisolone—psoriatic arthritis	0.000717	0.00274	CcSEcCtD
Gemfibrozil—Pancytopenia—Methotrexate—psoriatic arthritis	0.000708	0.00271	CcSEcCtD
Gemfibrozil—Vertigo—Triamcinolone—psoriatic arthritis	0.000707	0.0027	CcSEcCtD
Gemfibrozil—Syncope—Triamcinolone—psoriatic arthritis	0.000706	0.0027	CcSEcCtD
Gemfibrozil—Vertigo—Methylprednisolone—psoriatic arthritis	0.000705	0.00269	CcSEcCtD
Gemfibrozil—Syncope—Methylprednisolone—psoriatic arthritis	0.000704	0.00269	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000702	0.00268	CcSEcCtD
Gemfibrozil—Oedema—Prednisolone—psoriatic arthritis	0.000698	0.00267	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000698	0.00267	CcSEcCtD
Gemfibrozil—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000692	0.00264	CcSEcCtD
Gemfibrozil—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00069	0.00264	CcSEcCtD
Gemfibrozil—Shock—Prednisolone—psoriatic arthritis	0.000687	0.00262	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000687	0.00262	CcSEcCtD
Gemfibrozil—Cough—Triamcinolone—psoriatic arthritis	0.000687	0.00262	CcSEcCtD
Gemfibrozil—Convulsion—Triamcinolone—psoriatic arthritis	0.000682	0.0026	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000681	0.0026	CcSEcCtD
Gemfibrozil—Convulsion—Methylprednisolone—psoriatic arthritis	0.00068	0.0026	CcSEcCtD
Gemfibrozil—Myalgia—Triamcinolone—psoriatic arthritis	0.00067	0.00256	CcSEcCtD
Gemfibrozil—Myalgia—Methylprednisolone—psoriatic arthritis	0.000669	0.00255	CcSEcCtD
Gemfibrozil—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000669	0.00255	CcSEcCtD
Gemfibrozil—Eye disorder—Prednisone—psoriatic arthritis	0.000668	0.00255	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000664	0.00254	CcSEcCtD
Gemfibrozil—Depression—Methotrexate—psoriatic arthritis	0.000663	0.00253	CcSEcCtD
Gemfibrozil—Renal failure—Methotrexate—psoriatic arthritis	0.000654	0.0025	CcSEcCtD
Gemfibrozil—Angioedema—Dexamethasone—psoriatic arthritis	0.000652	0.00249	CcSEcCtD
Gemfibrozil—Angioedema—Betamethasone—psoriatic arthritis	0.000652	0.00249	CcSEcCtD
Gemfibrozil—Confusional state—Methylprednisolone—psoriatic arthritis	0.000646	0.00247	CcSEcCtD
Gemfibrozil—Oedema—Triamcinolone—psoriatic arthritis	0.000642	0.00245	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000642	0.00245	CcSEcCtD
Gemfibrozil—Vertigo—Dexamethasone—psoriatic arthritis	0.000642	0.00245	CcSEcCtD
Gemfibrozil—Vertigo—Betamethasone—psoriatic arthritis	0.000642	0.00245	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000641	0.00245	CcSEcCtD
Gemfibrozil—Syncope—Dexamethasone—psoriatic arthritis	0.00064	0.00245	CcSEcCtD
Gemfibrozil—Syncope—Betamethasone—psoriatic arthritis	0.00064	0.00245	CcSEcCtD
Gemfibrozil—Shock—Triamcinolone—psoriatic arthritis	0.000632	0.00241	CcSEcCtD
Gemfibrozil—Alopecia—Prednisone—psoriatic arthritis	0.000631	0.00241	CcSEcCtD
Gemfibrozil—Shock—Methylprednisolone—psoriatic arthritis	0.00063	0.00241	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000629	0.0024	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000628	0.0024	CcSEcCtD
Gemfibrozil—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000628	0.0024	CcSEcCtD
Gemfibrozil—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000628	0.0024	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisolone—psoriatic arthritis	0.000627	0.0024	CcSEcCtD
Gemfibrozil—Mental disorder—Prednisone—psoriatic arthritis	0.000626	0.00239	CcSEcCtD
Gemfibrozil—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000622	0.00238	CcSEcCtD
Gemfibrozil—Convulsion—Betamethasone—psoriatic arthritis	0.000619	0.00236	CcSEcCtD
Gemfibrozil—Convulsion—Dexamethasone—psoriatic arthritis	0.000619	0.00236	CcSEcCtD
Gemfibrozil—Myalgia—Dexamethasone—psoriatic arthritis	0.000608	0.00232	CcSEcCtD
Gemfibrozil—Myalgia—Betamethasone—psoriatic arthritis	0.000608	0.00232	CcSEcCtD
Gemfibrozil—Pain—Prednisolone—psoriatic arthritis	0.000597	0.00228	CcSEcCtD
Gemfibrozil—Vision blurred—Prednisone—psoriatic arthritis	0.000586	0.00224	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000585	0.00224	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000584	0.00223	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000583	0.00223	CcSEcCtD
Gemfibrozil—Oedema—Dexamethasone—psoriatic arthritis	0.000583	0.00223	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000583	0.00223	CcSEcCtD
Gemfibrozil—Oedema—Betamethasone—psoriatic arthritis	0.000583	0.00223	CcSEcCtD
Gemfibrozil—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000577	0.0022	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000576	0.0022	CcSEcCtD
Gemfibrozil—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000575	0.0022	CcSEcCtD
Gemfibrozil—Anaemia—Prednisone—psoriatic arthritis	0.000575	0.0022	CcSEcCtD
Gemfibrozil—Shock—Betamethasone—psoriatic arthritis	0.000573	0.00219	CcSEcCtD
Gemfibrozil—Shock—Dexamethasone—psoriatic arthritis	0.000573	0.00219	CcSEcCtD
Gemfibrozil—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000572	0.00218	CcSEcCtD
Gemfibrozil—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000572	0.00218	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000571	0.00218	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000571	0.00218	CcSEcCtD
Gemfibrozil—Angioedema—Prednisone—psoriatic arthritis	0.000568	0.00217	CcSEcCtD
Gemfibrozil—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000565	0.00216	CcSEcCtD
Gemfibrozil—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000564	0.00215	CcSEcCtD
Gemfibrozil—Vertigo—Prednisone—psoriatic arthritis	0.000559	0.00213	CcSEcCtD
Gemfibrozil—Eye disorder—Methotrexate—psoriatic arthritis	0.000558	0.00213	CcSEcCtD
Gemfibrozil—Syncope—Prednisone—psoriatic arthritis	0.000558	0.00213	CcSEcCtD
Gemfibrozil—Urticaria—Prednisolone—psoriatic arthritis	0.000555	0.00212	CcSEcCtD
Gemfibrozil—Fatigue—Triamcinolone—psoriatic arthritis	0.000554	0.00212	CcSEcCtD
Gemfibrozil—Fatigue—Methylprednisolone—psoriatic arthritis	0.000553	0.00211	CcSEcCtD
Gemfibrozil—Pain—Triamcinolone—psoriatic arthritis	0.000549	0.0021	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisone—psoriatic arthritis	0.000547	0.00209	CcSEcCtD
Gemfibrozil—Convulsion—Prednisone—psoriatic arthritis	0.000539	0.00206	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000538	0.00206	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000531	0.00203	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000531	0.00203	CcSEcCtD
Gemfibrozil—Myalgia—Prednisone—psoriatic arthritis	0.000529	0.00202	CcSEcCtD
Gemfibrozil—Arthralgia—Prednisone—psoriatic arthritis	0.000529	0.00202	CcSEcCtD
Gemfibrozil—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000529	0.00202	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000528	0.00202	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—psoriatic arthritis	0.000528	0.00202	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000526	0.00201	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000524	0.002	CcSEcCtD
Gemfibrozil—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000523	0.002	CcSEcCtD
Gemfibrozil—Paraesthesia—Betamethasone—psoriatic arthritis	0.000523	0.002	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—psoriatic arthritis	0.000523	0.002	CcSEcCtD
Gemfibrozil—Dyspepsia—Betamethasone—psoriatic arthritis	0.000513	0.00196	CcSEcCtD
Gemfibrozil—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000513	0.00196	CcSEcCtD
Gemfibrozil—Urticaria—Triamcinolone—psoriatic arthritis	0.00051	0.00195	CcSEcCtD
Gemfibrozil—Urticaria—Methylprednisolone—psoriatic arthritis	0.000509	0.00194	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—psoriatic arthritis	0.000509	0.00194	CcSEcCtD
Gemfibrozil—Oedema—Prednisone—psoriatic arthritis	0.000508	0.00194	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000508	0.00194	CcSEcCtD
Gemfibrozil—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000507	0.00194	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000503	0.00192	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000503	0.00192	CcSEcCtD
Gemfibrozil—Fatigue—Betamethasone—psoriatic arthritis	0.000502	0.00192	CcSEcCtD
Gemfibrozil—Fatigue—Dexamethasone—psoriatic arthritis	0.000502	0.00192	CcSEcCtD
Gemfibrozil—Shock—Prednisone—psoriatic arthritis	0.000499	0.00191	CcSEcCtD
Gemfibrozil—Pain—Betamethasone—psoriatic arthritis	0.000498	0.0019	CcSEcCtD
Gemfibrozil—Pain—Dexamethasone—psoriatic arthritis	0.000498	0.0019	CcSEcCtD
Gemfibrozil—Nervous system disorder—Prednisone—psoriatic arthritis	0.000498	0.0019	CcSEcCtD
Gemfibrozil—Skin disorder—Prednisone—psoriatic arthritis	0.000493	0.00188	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—psoriatic arthritis	0.00049	0.00187	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—psoriatic arthritis	0.00048	0.00183	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00048	0.00183	CcSEcCtD
Gemfibrozil—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00048	0.00183	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000477	0.00182	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000477	0.00182	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—psoriatic arthritis	0.000467	0.00178	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—psoriatic arthritis	0.000465	0.00178	CcSEcCtD
Gemfibrozil—Urticaria—Betamethasone—psoriatic arthritis	0.000463	0.00177	CcSEcCtD
Gemfibrozil—Urticaria—Dexamethasone—psoriatic arthritis	0.000463	0.00177	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000462	0.00177	CcSEcCtD
Gemfibrozil—Dizziness—Prednisolone—psoriatic arthritis	0.000462	0.00176	CcSEcCtD
Gemfibrozil—Asthenia—Triamcinolone—psoriatic arthritis	0.000461	0.00176	CcSEcCtD
Gemfibrozil—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000461	0.00176	CcSEcCtD
Gemfibrozil—Abdominal pain—Betamethasone—psoriatic arthritis	0.000461	0.00176	CcSEcCtD
Gemfibrozil—Asthenia—Methylprednisolone—psoriatic arthritis	0.00046	0.00176	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisone—psoriatic arthritis	0.000456	0.00174	CcSEcCtD
Gemfibrozil—Pruritus—Triamcinolone—psoriatic arthritis	0.000454	0.00174	CcSEcCtD
Gemfibrozil—Cough—Methotrexate—psoriatic arthritis	0.000454	0.00173	CcSEcCtD
Gemfibrozil—Pruritus—Methylprednisolone—psoriatic arthritis	0.000453	0.00173	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—psoriatic arthritis	0.00045	0.00172	CcSEcCtD
Gemfibrozil—Dyspepsia—Prednisone—psoriatic arthritis	0.000447	0.00171	CcSEcCtD
Gemfibrozil—Chest pain—Methotrexate—psoriatic arthritis	0.000442	0.00169	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—psoriatic arthritis	0.000442	0.00169	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—psoriatic arthritis	0.000442	0.00169	CcSEcCtD
Gemfibrozil—Rash—Prednisolone—psoriatic arthritis	0.00044	0.00168	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisolone—psoriatic arthritis	0.00044	0.00168	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000439	0.00168	CcSEcCtD
Gemfibrozil—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000438	0.00167	CcSEcCtD
Gemfibrozil—Fatigue—Prednisone—psoriatic arthritis	0.000438	0.00167	CcSEcCtD
Gemfibrozil—Headache—Prednisolone—psoriatic arthritis	0.000438	0.00167	CcSEcCtD
Gemfibrozil—Constipation—Prednisone—psoriatic arthritis	0.000434	0.00166	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—psoriatic arthritis	0.000428	0.00163	CcSEcCtD
Gemfibrozil—Dizziness—Triamcinolone—psoriatic arthritis	0.000425	0.00162	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000424	0.00162	CcSEcCtD
Gemfibrozil—Dizziness—Methylprednisolone—psoriatic arthritis	0.000424	0.00162	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisone—psoriatic arthritis	0.000418	0.0016	CcSEcCtD
Gemfibrozil—Asthenia—Betamethasone—psoriatic arthritis	0.000418	0.0016	CcSEcCtD
Gemfibrozil—Asthenia—Dexamethasone—psoriatic arthritis	0.000418	0.0016	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000416	0.00159	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000415	0.00159	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000415	0.00159	CcSEcCtD
Gemfibrozil—Nausea—Prednisolone—psoriatic arthritis	0.000415	0.00158	CcSEcCtD
Gemfibrozil—Pruritus—Betamethasone—psoriatic arthritis	0.000412	0.00157	CcSEcCtD
Gemfibrozil—Pruritus—Dexamethasone—psoriatic arthritis	0.000412	0.00157	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—psoriatic arthritis	0.000412	0.00157	CcSEcCtD
Gemfibrozil—Vomiting—Triamcinolone—psoriatic arthritis	0.000408	0.00156	CcSEcCtD
Gemfibrozil—Vomiting—Methylprednisolone—psoriatic arthritis	0.000407	0.00156	CcSEcCtD
Gemfibrozil—Rash—Triamcinolone—psoriatic arthritis	0.000405	0.00155	CcSEcCtD
Gemfibrozil—Dermatitis—Triamcinolone—psoriatic arthritis	0.000405	0.00155	CcSEcCtD
Gemfibrozil—Rash—Methylprednisolone—psoriatic arthritis	0.000404	0.00154	CcSEcCtD
Gemfibrozil—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000404	0.00154	CcSEcCtD
Gemfibrozil—Urticaria—Prednisone—psoriatic arthritis	0.000403	0.00154	CcSEcCtD
Gemfibrozil—Headache—Triamcinolone—psoriatic arthritis	0.000402	0.00154	CcSEcCtD
Gemfibrozil—Headache—Methylprednisolone—psoriatic arthritis	0.000401	0.00153	CcSEcCtD
Gemfibrozil—Abdominal pain—Prednisone—psoriatic arthritis	0.000401	0.00153	CcSEcCtD
Gemfibrozil—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000399	0.00152	CcSEcCtD
Gemfibrozil—Diarrhoea—Betamethasone—psoriatic arthritis	0.000399	0.00152	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000386	0.00148	CcSEcCtD
Gemfibrozil—Dizziness—Dexamethasone—psoriatic arthritis	0.000385	0.00147	CcSEcCtD
Gemfibrozil—Dizziness—Betamethasone—psoriatic arthritis	0.000385	0.00147	CcSEcCtD
Gemfibrozil—Nausea—Triamcinolone—psoriatic arthritis	0.000382	0.00146	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—psoriatic arthritis	0.000381	0.00145	CcSEcCtD
Gemfibrozil—Nausea—Methylprednisolone—psoriatic arthritis	0.000381	0.00145	CcSEcCtD
Gemfibrozil—Somnolence—Methotrexate—psoriatic arthritis	0.000377	0.00144	CcSEcCtD
Gemfibrozil—Dyspepsia—Methotrexate—psoriatic arthritis	0.000373	0.00143	CcSEcCtD
Gemfibrozil—Vomiting—Betamethasone—psoriatic arthritis	0.000371	0.00142	CcSEcCtD
Gemfibrozil—Vomiting—Dexamethasone—psoriatic arthritis	0.000371	0.00142	CcSEcCtD
Gemfibrozil—Rash—Dexamethasone—psoriatic arthritis	0.000367	0.0014	CcSEcCtD
Gemfibrozil—Rash—Betamethasone—psoriatic arthritis	0.000367	0.0014	CcSEcCtD
Gemfibrozil—Dermatitis—Betamethasone—psoriatic arthritis	0.000367	0.0014	CcSEcCtD
Gemfibrozil—Dermatitis—Dexamethasone—psoriatic arthritis	0.000367	0.0014	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000366	0.0014	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—psoriatic arthritis	0.000366	0.0014	CcSEcCtD
Gemfibrozil—Headache—Betamethasone—psoriatic arthritis	0.000365	0.00139	CcSEcCtD
Gemfibrozil—Headache—Dexamethasone—psoriatic arthritis	0.000365	0.00139	CcSEcCtD
Gemfibrozil—Asthenia—Prednisone—psoriatic arthritis	0.000364	0.00139	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—psoriatic arthritis	0.000363	0.00139	CcSEcCtD
Gemfibrozil—Pruritus—Prednisone—psoriatic arthritis	0.000359	0.00137	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00035	0.00134	CcSEcCtD
Gemfibrozil—Diarrhoea—Prednisone—psoriatic arthritis	0.000347	0.00133	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000347	0.00132	CcSEcCtD
Gemfibrozil—Nausea—Dexamethasone—psoriatic arthritis	0.000346	0.00132	CcSEcCtD
Gemfibrozil—Nausea—Betamethasone—psoriatic arthritis	0.000346	0.00132	CcSEcCtD
Gemfibrozil—Urticaria—Methotrexate—psoriatic arthritis	0.000337	0.00129	CcSEcCtD
Gemfibrozil—Dizziness—Prednisone—psoriatic arthritis	0.000336	0.00128	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—psoriatic arthritis	0.000335	0.00128	CcSEcCtD
Gemfibrozil—Vomiting—Prednisone—psoriatic arthritis	0.000323	0.00123	CcSEcCtD
Gemfibrozil—Rash—Prednisone—psoriatic arthritis	0.00032	0.00122	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisone—psoriatic arthritis	0.00032	0.00122	CcSEcCtD
Gemfibrozil—Headache—Prednisone—psoriatic arthritis	0.000318	0.00121	CcSEcCtD
Gemfibrozil—Asthenia—Methotrexate—psoriatic arthritis	0.000304	0.00116	CcSEcCtD
Gemfibrozil—Nausea—Prednisone—psoriatic arthritis	0.000301	0.00115	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—psoriatic arthritis	0.0003	0.00115	CcSEcCtD
Gemfibrozil—Diarrhoea—Methotrexate—psoriatic arthritis	0.00029	0.00111	CcSEcCtD
Gemfibrozil—Dizziness—Methotrexate—psoriatic arthritis	0.00028	0.00107	CcSEcCtD
Gemfibrozil—Vomiting—Methotrexate—psoriatic arthritis	0.00027	0.00103	CcSEcCtD
Gemfibrozil—Rash—Methotrexate—psoriatic arthritis	0.000267	0.00102	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—psoriatic arthritis	0.000267	0.00102	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—psoriatic arthritis	0.000266	0.00101	CcSEcCtD
Gemfibrozil—Nausea—Methotrexate—psoriatic arthritis	0.000252	0.000962	CcSEcCtD
